Related Experiment Video
Updated: Aug 9, 2026

Production and Testing of Antimicrobial Peptides and Their Mimics
Published on: April 10, 2026
Antimicrobial Peptides (AMPs) as Potential Antibiotics: Classification, Development and Future Prospects in Combating
Vrushali Raka1,2, Hemraj Nandanwar1,2
1Clinical Microbiology and Antimicrobial Research Laboratory, CSIR-Institute of Microbial Technology, Sector 39-A, Chandigarh, India.
Antimicrobial peptides (AMPs) offer a novel solution to combat antimicrobial resistance (AMR). This review explores their mechanisms, challenges, and potential as next-generation antibiotics.
Area of Science:
- Biochemistry and Molecular Biology
- Infectious Diseases
- Drug Discovery
Background:
- Antimicrobial resistance (AMR) necessitates novel therapeutic strategies.
- Antimicrobial peptides (AMPs) are key components of innate immunity with broad-spectrum activity.
- AMPs present unique mechanisms of action that bacteria find difficult to develop resistance against.
Purpose of the Study:
- To review the classification, mechanisms, and therapeutic potential of AMPs.
- To highlight innovations in AMP development for combating AMR.
- To provide a foundation for coherent AMP development strategies.
Main Methods:
- Literature review of AMPs' structure, origin, and mode of action.
- Analysis of challenges in AMP development (stability, toxicity, cost).
- Examination of advancements in peptide engineering and synthetic biology.
Main Results:
- AMPs exhibit versatile mechanisms distinct from conventional antibiotics.
- Peptide engineering and synthetic biology are addressing development challenges.
- AMPs show potential for synergistic use with existing drugs and personalized medicine.
Conclusions:
- AMPs are promising candidates for next-generation antibiotics to combat AMR.
- Interdisciplinary approaches and regulatory frameworks are crucial for clinical translation.
- Accelerating AMP development is vital for managing antibiotic-resistant infections.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Inhibitors of Bacterial Protein Synthesis
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
